Specifically, 18F-PSMA-FAPI-01 and 18F -PSMA-FAPI-02 showed increased tumor uptake in comparison to the monomeric radiotracers 18F-FAPI-42 and 18F-PSMA-BCH, with an optimal pharmacokinetics profile [185]. The gene discussed is FOLH1; the disease is neoplasm.